Gainers AtaiBeckley (NASDAQ:ATAI) stock rose 34.3% to $7.2 during Thursday's pre-market session

Dear Fellow Shareholders,Following several significant developments in recent weeks, I wanted to pro

Fiscal 2026 Annual Report, filed July 2, 2026, reflects cash of $6.4 million, total assets of $8.3 m

LONDON, July 10, 2026 /PRNewswire/ -- Virax Biolabs Group Limited ("Virax" or the "Company") (Nasdaq

Gainers EUDA Health Holdings (NASDAQ:EUDA) shares rose 22.3% to $15.2 during Friday's regular s

Dow Jones up 0.1% on Friday with NASDAQ and S&P 500 also rising. Communication services shares j

Dow Jones up 0.1%, Nasdaq up 0.07%, S&P 500 up 0.11%. Communication services up 0.9% and Health

Gainers AVITA Medical (NASDAQ:RCEL) stock moved upwards by 11.1% to $4.9 during Thursday's afte

LONDON, July 9, 2026 /PRNewswire/ -- Virax Biolabs Group Limited ("Virax" or the "Company") (Nasdaq:

Gainers Virax Biolabs Group (NASDAQ:VRAX) shares rose 178.9% to $8.87 during Thursday's regular

Virax Biolabs (VRAX) shares exploded higher on Thursday morning after management announced a lucrati

U.S. stocks higher, Dow gains over 150 points. NASDAQ up 0.84%, S&P 500 up 0.60%. Tech shares ju

Virax Biolabs Group Limited (NASDAQ:VRAX) stock is up during Thursday's premarket session, as the co

US stocks mixed, Nasdaq up 0.46% as Dow drops 0.06%. Tech shares surge 1.4%, consumer staples fall 1

Gainers Virax Biolabs Group (NASDAQ:VRAX) stock increased by 134.0% to $7.44 during Thursday's

LONDON, July 9, 2026 /PRNewswire/ -- Virax Biolabs Group Limited (NASDAQ: VRAX) ("Virax" or the "Com

LONDON, June 24, 2026 /PRNewswire/ -- Virax Biolabs Group Limited (NASDAQ: VRAX) ("Virax" or the "Co

LONDON, May 26, 2026 /PRNewswire/ -- Virax Biolabs Group Limited (NASDAQ: VRAX) ("Virax" or the "Com

Agilysys Inc (AGYS) shares rose in pre-market trading after reporting better-than-expected financial

Virax Biolabs is advancing a focused strategy centered on ViraxImmune™ and a U.S. market-entry pathw

IDEAYA Biosciences shares (NASDAQ: IDYA) jumped 18% in pre-market trading after announcing topline

Virax Biolabs said that Virax Biolabs (UK) Limited, its wholly owned subsidiary, has achieved ISO 13

LONDON, March 31, 2026 /PRNewswire/ -- Virax Biolabs Group Limited (NASDAQ: VRAX) ("Virax" or the "C

Virax Biolabs Group Limited (NASDAQ: VRAX - Get Free Report) was the target of a significant growth

Virax Biolabs Group Limited (NASDAQ: VRAX - Get Free Report) saw a large drop in short interest in t

Virax Biolabs Group Limited (NASDAQ: VRAX - Get Free Report)'s stock price dropped 5.3% on Friday. T

Virax Biolabs Group Limited (VRAX) might move higher on growing optimism about its earnings prospect